These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38360242)

  • 1. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress.
    Kothari M; Kannan K; Sahadevan R; Sadhukhan S
    Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting
    Gohar NA; Fayed EA; A Ammar Y; A Abu Ali O; Ragab A; Mahfoz AM; Abusaif MS
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2367128. PubMed ID: 38913598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities.
    Hameed S; Khan KM; Salar U; Özil M; Baltaş N; Saleem F; Qureshi U; Taha M; Ul-Haq Z
    Int J Biol Macromol; 2022 Nov; 221():1294-1312. PubMed ID: 36113601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation.
    Ragab A; Salem MA; Ammar YA; Aboulthana WM; Helal MH; Abusaif MS
    Drug Dev Res; 2024 Jun; 85(4):e22216. PubMed ID: 38831547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
    Zahra S; Zaib S; Khan I
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.
    Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y
    Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel 4,5-diphenyl-imidazol-α-aminophosphonate hybrids as promising anti-diabetic agents: Design, synthesis, in vitro, and in silico enzymatic studies.
    Zareei S; Ranjbar S; Mohammadi M; Ghasemi Y; Golestanian S; Avizheh L; Moazzam A; Larijani B; Mohammadi-Khanaposhtani M; Tarahomi MM; Mahdavi M; Sadeghian N; Taslimi P
    Bioorg Chem; 2023 Dec; 141():106846. PubMed ID: 37713948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation.
    Singh G; Singh R; Monga V; Mehan S
    Eur J Med Chem; 2024 Feb; 266():116139. PubMed ID: 38252989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes.
    Zhang K; Chen XL; Zhao X; Ni JY; Wang HL; Han M; Zhang YM
    J Ethnopharmacol; 2022 Jun; 291():115118. PubMed ID: 35202712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic.
    Phongphane L; Mohd Radzuan SN; Abu Bakar MH; Che Omar MT; Supratman U; Harneti D; A Wahab H; Azmi MN
    Comput Biol Chem; 2023 Oct; 106():107938. PubMed ID: 37542847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation.
    Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A
    Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
    Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
    Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes.
    Alasmary FAS; Abdullah DA; Masand VH; Ben Bacha A; Omar Ebeid AM; El-Araby ME; Alafeefy AM
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2395985. PubMed ID: 39311475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
    Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
    Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone
    Akinyede KA; Oyewusi HA; Hughes GD; Ekpo OE; Oguntibeju OO
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.
    Ritu ; Sharma P; Gupta GD; Asati V
    Bioorg Chem; 2023 Oct; 139():106750. PubMed ID: 37499530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary Flavonoids and Acarbose Synergistically Inhibit α-Glucosidase and Lower Postprandial Blood Glucose.
    Zhang BW; Li X; Sun WL; Xing Y; Xiu ZL; Zhuang CL; Dong YS
    J Agric Food Chem; 2017 Sep; 65(38):8319-8330. PubMed ID: 28875706
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation.
    Luo S; Zhao L; Peng H; Peng Z; Wang G
    Eur J Med Chem; 2024 Sep; 275():116600. PubMed ID: 38889608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.